ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 84 filers reported holding ADICET BIO INC in Q3 2023. The put-call ratio across all filers is 7.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274,275 | -77.7% | 200,201 | -60.4% | 0.09% | -76.1% |
| Q2 2023 | $1,228,773 | -63.2% | 505,668 | -12.8% | 0.38% | -71.4% |
| Q1 2023 | $3,340,800 | -35.6% | 580,000 | 0.0% | 1.35% | -30.6% |
| Q4 2022 | $5,185,200 | -37.1% | 580,000 | 0.0% | 1.94% | -35.1% |
| Q3 2022 | $8,248,000 | -2.6% | 580,000 | 0.0% | 2.99% | -6.9% |
| Q2 2022 | $8,468,000 | -26.9% | 580,000 | 0.0% | 3.21% | -9.5% |
| Q1 2022 | $11,583,000 | – | 580,000 | – | 3.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |